Genitourinary Cancer
News
PSA Level Could Determine Screening Frequency in 40s
News
U.S. Task Force Confirms Stance Against Universal PSA Screening
News
Neoadjuvant Abiraterone Helps Clear Aggressive, Early Stage Prostate Tumors
Major Finding: At 24 weeks, a pathological complete response or near pCR was achieved by 34% of men randomized to neoadjuvant abiraterone...
News
NICE Reverses Course on Abiraterone
News
FDA Approves Everolimus for Noncancerous Kidney Tumor Indication
News
Prostate Cancer Survivors Avoid Therapy for Sexual Side Effects
News
Maintenance Immunotherapy Extends Survival in Multiple Advanced Cancers
News
Radiotherapy Comparison Favors IMRT for Prostate Cancer
Major Finding: Men who received IMRT were about 20% less likely to receive additional cancer therapy with an absolute risk of 2.5 vs. 3.1 per 100...
News
Galeterone Lowers PSA in Castration-Resistant Prostate Cancer
Major Finding: In all, 24 of 49 men with castration-resistant prostate cancer achieved reductions in PSA levels of at least 30% when treated with...
Commentary
Technology Trumps Outcomes in Prostate Cancer Reimbursement
News
Circumcision May Lower Prostate Cancer Risk
Major Finding: Men who were circumcised before their first sexual intercourse had a 15% reduction in relative risk, compared with men who were...